RespiGam: an RSV immune globulin. (respiratory syncytial virus)(Evaluation): An article from: Pediatric Nursing
Book Details
Author(s)Maryann D. Oertel
PublisherJannetti Publications, Inc.
ISBN / ASINB00096Q41Y
ISBN-13978B00096Q412
MarketplaceFrance 🇫🇷
Description
This digital document is an article from Pediatric Nursing, published by Jannetti Publications, Inc. on November 1, 1996. The length of the article is 3638 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
From the supplier: RespiGam, a respiratory syncytial virus (RSV) immune globulin, appears effective in preventing or minimizing the severity of RSV infection in premature infants and infants with bronchopulmonary dysplasia. In one study, RespiGam reduced RSV lower respiratory tract infections by 62% and moderate or severe RSV infections by 72% when compared with those in a control group. Side effects include fever, headache, and nausea, in addition to wheezing or respiratory distress in a small number of patients. RespiGam is administered intravenously, and is quite expensive.
Citation Details
Title: RespiGam: an RSV immune globulin. (respiratory syncytial virus)(Evaluation)
Author: Maryann D. Oertel
Publication:Pediatric Nursing (Refereed)
Date: November 1, 1996
Publisher: Jannetti Publications, Inc.
Volume: v22 Issue: n6 Page: p525(4)
Article Type: Evaluation, Product/Service Evaluation
Distributed by Thomson Gale
From the supplier: RespiGam, a respiratory syncytial virus (RSV) immune globulin, appears effective in preventing or minimizing the severity of RSV infection in premature infants and infants with bronchopulmonary dysplasia. In one study, RespiGam reduced RSV lower respiratory tract infections by 62% and moderate or severe RSV infections by 72% when compared with those in a control group. Side effects include fever, headache, and nausea, in addition to wheezing or respiratory distress in a small number of patients. RespiGam is administered intravenously, and is quite expensive.
Citation Details
Title: RespiGam: an RSV immune globulin. (respiratory syncytial virus)(Evaluation)
Author: Maryann D. Oertel
Publication:Pediatric Nursing (Refereed)
Date: November 1, 1996
Publisher: Jannetti Publications, Inc.
Volume: v22 Issue: n6 Page: p525(4)
Article Type: Evaluation, Product/Service Evaluation
Distributed by Thomson Gale
